4Sc AG operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares 4Sc AG with three other
miscellaneous service companies in Europe:
sales of 2.14 million Euros [US$2.59 million]
of which 100%
was Regenerative Medicine),
Fusion Antibodies PLC
of UNITED KINGDOM
(£2.18 million [US$2.97 million]
Kuros Biosciences AG
based in SWITZERLAND
(2.56 million Swiss Francs [US$2.88 million]
4Sc AG reported sales of 2.20 million Euro (US$2.66 million)
December of 2019.
decrease of 47.4%
versus 2018, when the company's sales were 4.17 million Euro.